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Introduction
The proper repair of double-strand breaks (DSBs) that occur 
during DNA replication is heavily dependent on error-free 
homologous recombination (HR; Schwartz and Heyer, 2011; 
Heyer, 2015). However, DSBs may also be repaired by the di-
rect ligation of DNA ends through nonhomologous end joining 
(NHEJ). Because of the risk of ligating wrong ends and/or de-
leting DNA sequences, NHEJ is considered to be an error-prone 
repair mechanism. During DNA replication, NHEJ repair has 
been proposed to be deleterious because of the intrinsic in-
creased incidence of breaks, especially of one-ended DSBs, 
whose inappropriate joining could lead to dicentric chromo-
somes that initiate break–fusion cycles and complex chromo-
some rearrangements (Gaillard et al., 2015; Gelot et al., 2015). 
Therefore, NHEJ-mediated mutagenic repair is believed to be 
a major contributor to genomic instabilities and tumorigenesis 
that arise when the HR machinery is defective (Deng and Wang, 
2003; Prakash et al., 2015). The ability of cells to inhibit NHEJ 
and promote error-free HR repair during DNA replication is es-
sential for genome integrity.
A critical step in regulating the choice of HR or NHEJ 
for repair is the control of 5′-to-3′ nucleolytic processing of 
DNA ends (also known as resection), as the formation of long 
3′ single-stranded DNA (ssDNA) tails naturally promotes HR 
while preventing NHEJ (Chapman et al., 2012b; Prakash et al., 
2015). 53BP1 is a scaffolding protein that plays a major role in 
limiting resection (Bothmer et al., 2010; Bunting et al., 2010). 
Although the mechanism by which 53BP1 limits resection 
remains incompletely understood, it involves the 53BP1-de-
pendent recruitment of additional anti-resection factors such 
as RIF1 (Callen et al., 2013; Chapman et al., 2013; Di Vir-
gilio et al., 2013; Escribano-Díaz et al., 2013; Zimmermann 
et al., 2013; Kumar and Cheok, 2014). On the other hand, in 
S phase, the tumor suppressor BRCA1 is proposed to play a 
pro-HR function by counteracting the recruitment of 53BP1 to 
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DSBs, therefore enabling resection (Bunting et al., 2010). This 
model is supported by genetic data in mice showing that the 
loss of 53BP1 suppresses embryonic lethality, genomic rear-
rangements, and tumorigenesis seen in mice lacking functional 
BRCA1 (Cao et al., 2009; Bouwman et al., 2010; Bunting et 
al., 2010; Prakash et al., 2015). DNA end resection is inhibited 
during the S phase in cells lacking BRCA1, and the increased 
recruitment of 53BP1 to replication-induced lesions results in 
increased chromosomal aberrations, which has been suggested 
to occur through mutagenic NHEJ repair (Bunting et al., 2010; 
Escribano-Díaz et al., 2013). Collectively, these observations 
support a model for repair pathway choice in which BRCA1 
and 53BP1 compete for the sites of DNA lesions to promote 
HR or NHEJ. Despite strong genetic evidence supporting this 
model, it remains unclear exactly how 53BP1 promotes chro-
mosomal instabilities upon BRCA1 dysfunction, as NHEJ is 
not the only potential source of mutagenic repair. For example, 
deregulated HR also has the potential to result in genomic in-
stabilities, such as gross chromosomal rearrangements, caused 
by recombination between nonallelic sequences (Kolodner et 
al., 2002; Carr and Lambert, 2013). The role of BRCA1 in sup-
pressing genomic instability during DNA replication may be 
dependent not only on counteracting 53BP1-mediated NHEJ, 
but also on ensuring that HR is properly executed for error-free 
repair. Although several mechanisms have been proposed to 
explain how the competition between BRCA1 and 53BP1 for 
DNA lesions is regulated (Kakarougkas et al., 2013; Tang et al., 
2013; Orthwein et al., 2015; Zhang et al., 2016), the molecular 
mechanism by which BRCA1 is able to efficiently counteract 
53BP1 during replication stress to favor DNA end resection re-
mains incompletely understood.
Although many aspects of mammalian DNA repair are 
conserved in budding yeast, it remains unknown whether key 
mechanisms of HR control and DNA repair pathway choice 
are also conserved. Notably, a clear sequence homologue or a 
functional analogue of BRCA1 has not been identified in fungi. 
However, the 53BP1 orthologue Rad9 has been shown to play 
a conserved role in blocking resection (Lazzaro et al., 2008; 
Clerici et al., 2014; Ferrari et al., 2015). Cells lacking RAD9 
resect DSBs faster and more extensively (Lazzaro et al., 2008; 
Chen et al., 2012; Clerici et al., 2014). Of importance, it was 
recently proposed that a complex formed by the DNA repair 
scaffolds Slx4 and Rtt107 is able to counteract the engagement 
of Rad9 at replication-induced lesions to dampen DNA dam-
age checkpoint signaling (Ohouo et al., 2013). Given the roles 
of Rad9 in blocking resection, we predicted that the ability of 
the Slx4–Rtt107 complex to counteract Rad9 recruitment to 
DNA lesions would help avert the block, therefore promoting 
resection. Indeed, recent work presented experimental evi-
dence that the Slx4–Rtt107 complex favors resection of DSBs 
(Dibitetto et al., 2016).
Mammalian TOP BP1Dpb11 is an essential scaffolding pro-
tein that plays evolutionarily conserved roles in the initiation 
of DNA replication and activation of DNA damage checkpoint 
signaling (Tanaka et al., 2007; Zegerman and Diffley, 2007; 
Navadgi-Patil and Burgers, 2008; Puddu et al., 2008; Boos et 
al., 2011; Pfander and Diffley, 2011). TOP BP1Dpb11 is com-
prised of multiple BRCA1 C terminus (BRCT) domains (nine 
in humans and four in yeast), which are protein-interacting 
modules that often recognize phosphorylated motifs (Manke et 
al., 2003; Rodriguez et al., 2003; Yu et al., 2003). TOP BP1Dpb11 
recognizes phosphoproteins to assemble the multisubunit 
complexes required for replication initiation or checkpoint ac-
tivation (Tak et al., 2006; Zegerman and Diffley, 2007; Boos et 
al., 2011; Pfander and Diffley, 2011). Although TOP BP1 has 
been implicated in HR repair (Morishima et al., 2007; Germann 
et al., 2011; Liu and Smolka, 2016; Moudry et al., 2016), its 
precise role and mode of action remain largely elusive. In this 
study, we show that in budding yeast, Dpb11 plays a decisive 
role in the control of DNA end resection, the first key step in 
HR, by mediating a competition between the anti-resection 
protein Rad9 and the pro-resection scaffolds Slx4–Rtt107 for 
DNA lesions. In humans, we find that TOP BP1 coordinates 
the recruitment of 53BP1 via a physical interaction that ap-
pears to be mutually exclusive with that of the pro-HR factor 
BRCA1. Our results support a model in which TOP BP1Dpb11 
controls the mutually exclusive engagement of antagonistic reg-
ulators of recombinational DNA repair for the proper mainte-
nance of genome integrity.
Results
BRCT domains of Dpb11 mediate  
mutually antagonistic functions in  
DNA end resection
In budding yeast, Dpb11 has been shown to recruit Rad9 to 
the 9-1-1 clamp (composed of Ddc1-Mec3-Rad17 in budding 
yeast and RAD9-HUS1-RAD1 in mammals) loaded at DNA 
lesions to promote activation of the DNA damage checkpoint 
(Fig. 1 A; Granata et al., 2010; Pfander and Diffley, 2011; Wang 
et al., 2012; Abreu et al., 2013). Because Rad9 and its human 
orthologue 53BP1 have both been shown to block DNA end 
resection, we hypothesized that the role of Dpb11 in mediat-
ing the recruitment of Rad9 to DNA breaks plays a decisive 
role in resection control and HR-mediated DNA repair. To test 
this, we fused BRCT domains 3/4 of Dpb11 with full-length 
Rad9 (Fig. 1 B), with the expectation that this chimera would 
hyperstabilize Rad9 at DNA lesions and block resection. Using 
a system to induce a persistent DSB at the mating-type (MAT) 
locus through the overexpression of homothallic switching 
(HO) endonuclease (White and Haber, 1990; Lee et al., 1998), 
we found that the Dpb11BRCT3/4-Rad9 chimera (hereafter re-
ferred to as “BRCT3/4-Rad9”) is robustly detected at 0.15 
kb from the break site using chromatin immunoprecipitation 
(ChIP)–quantitative PCR (qPCR; Fig. 1 C). Of importance, a 
point mutation corresponding to K544A in Dpb11, known to 
disrupt the ability of BRCT3/4 to recognize phosphorylated 
9-1-1, prevents the stabilization of BRCT3/4-Rad9 near the 
site of DSB (Fig.  1  C). Taking advantage of this system, we 
assessed the effect of Dpb11-mediated Rad9 hyperstabilization 
on resected DNA ends using an assay to monitor the accumu-
lation of ssDNA flanking an irreparable HO-induced DSB site 
(Ferrari et al., 2015; Dibitetto et al., 2016). Although we did not 
observe an impact on resection at 0.15 kb from the break, re-
section is significantly inhibited at 1.4 kb and severely blocked 
at 4.8 kb from the break site upon expression of the BRCT3/4-
Rad9 chimera (Fig.  1  D). The K544A mutation that impairs 
BRCT3/4 fully restored resection, arguing that the ability of 
Dpb11 to bridge Rad9 to the 9-1-1 complex is crucial to inhibit 
long-range resection. Consistent with this model, expression of 
the BRCT3/4-Rad9 chimera strongly impaired the repair of one 
HO cut through a single-strand annealing (SSA) mechanism 
that relies on extensive resection (Fig. 1, E–G).
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Figure 1. A competition-based mechanism for the modulation of Rad9 recruitment and DNA end resection via Dpb11 BRCT domains. (A) Working model 
for the role of Dpb11 in the recruitment of Rad9 to the 5′ recessed end of a DNA lesion. (B) Schematic illustration of the BRCT3/4-Rad9 chimera. (C) 
ChIP-qPCR analysis showing the recruitment of BRCT3/4-Rad9 to an HO-induced DSB site. JKM139-derivative strains expressing the indicated chimera 
proteins or an untagged Rad9 control were arrested with nocodazole, and HO endonuclease expression was then induced for the indicated time to trigger 
an irreparable DSB on chromosome III. (D) HO-induced DSB resection analysis by qPCR in nocodazole-arrested JKM139-derivative strains expressing the 
indicated Rad9 constructs. (E) Schematic illustration for the SSA repair assay measurement. The graph shows the YMV80 chromosome III region containing 
an HO cut site. The DNA probe hybridizes to sequences within the indicated black boxes. K, KpnI cut site. (F) Successful SSA requires 25-kb resection and 
can be monitored by the appearance of a 3.5-kb SSA product using Southern blot analysis (shown here), where an ATG5 (uncut locus on chromosome 
XVI) probe (marked by an asterisk) was used to normalize the signals. HOcs, HO cut site. (G) Exponentially growing YMV80-derivative strains of each 
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We have recently proposed a model in which Dpb11 also 
coordinates the controlled disengagement of Rad9 from lesions 
for dampening checkpoint signaling (Fig.  1  H; Ohouo et al., 
2013; Cussiol et al., 2015). In this model, the Slx4–Rtt107 
scaffolding complex competes with Rad9 for Dpb11 interac-
tion, ultimately preventing Rad9 from stabilizing at DNA le-
sions. We hypothesized that this competition mechanism is also 
crucial to control the roles of Rad9 in DNA repair and could 
provide the molecular basis to understand how 53BP1 recruit-
ment is regulated in mammals. We predicted that a fusion of the 
Slx4–Rtt107 complex with Dpb11 BRCT3/4 should be able to 
antagonize the BRCT3/4-Rad9 chimera and restore resection. 
We have previously shown that a fusion of Dpb11 BRCT3/4 
with Rtt107 BRCT5/6 (referred as the minimal multi-BRCT 
domain [MBD] module; Fig. 1 I) mimics the role of the Dpb11–
Slx4–Rtt107 complex in checkpoint dampening (Cussiol et al., 
2015). Here, we found that expression of MBD prevents hyper-
stabilization of the BRCT3/4-Rad9 chimera at DSBs (Fig. 1 J) 
and, strikingly, fully suppresses the resection block induced by 
BRCT3/4-Rad9 (Fig. 1 K). Collectively, these results are con-
sistent with a model in which Dpb11 plays mutually antagonis-
tic roles in resection by coordinating the stabilization as well 
as the exclusion of Rad9 from DNA lesions (Fig. 1, H and L).
Dpb11-mediated recruitment of Rad9 
impairs HR-mediated repair in response  
to replication stress
Slx4 and Rtt107 have been shown to be particularly important 
in the response to methyl methanesulfonate (MMS)–induced 
replication stress (Fricke and Brill, 2003; Chin et al., 2006; 
Roberts et al., 2006; Ohouo et al., 2010). We therefore asked 
whether the BRCT3/4-Rad9 chimera also impairs the control of 
resection and HR-mediated repair in cells treated with MMS, a 
DNA alkylating agent that blocks replication fork progression. 
Although MMS treatment resulted in the formation of multiple 
replication protein A (RPA) foci, an indirect marker of ssDNA 
exposure, in cells expressing the mutated BRCT3/4(K544A)-
Rad9 chimera, expression of the chimera BRCT3/4-Rad9 
bearing functional BRCT3/4 prevented most cells from accumu-
lating multiple RPA foci (Fig. 2, A and B), consistent with the 
lower accumulation of ssDNA at replication forks likely caused 
by the inhibition of DNA end resection. This defect in RPA foci 
formation is accompanied by a severe reduction in foci forma-
tion of the HR protein Rad52 (Fig. 2, C and D), pointing to an 
impairment of HR-mediated repair. Of note, coexpression of the 
MBD chimera restored the accumulation of RPA and Rad52 
foci in cells expressing the BRCT3/4-Rad9 chimera. These 
results support that Dpb11-mediated recruitment of Rad9 also 
plays an important role in coordinating DNA end resection and 
HR repair in the response to replication blocks. MBD coexpres-
sion or K544A mutation in the BRCT3/4-Rad9 chimera were 
also sufficient to rescue BRCT3/4-Rad9–induced MMS sensi-
tivity (Fig. 2, E and F). Furthermore, expression of BRCT3/4-
Rad9 led to hyperactivation of the checkpoint effector kinase 
Rad53 in cells treated with MMS as evaluated by the mobility 
shift of Rad53 (Fig. 2 G), consistent with the Dpb11-mediated 
function of Rad9 in promoting checkpoint signaling. This ab-
errant Rad53 hyperphosphorylation, as well as the appearance 
of a hypershifted form of BRCT3/4-Rad9, was suppressed by 
the coexpression of MBD, which is in agreement with the re-
duced binding of BRCT3/4-Rad9 nearby an HO-induced DSB 
upon MBD expression. These data again reinforce the com-
petition-based model in which Dpb11 regulates HR-mediated 
repair by coordinating the mutually exclusive recruitment of 
Slx4 and Rad9 and reveal that Dpb11 plays antagonistic roles 
in HR-mediated repair also in the context of replication stress.
The Mec1 kinase promotes resection via 
phosphorylation of Slx4
According to our model, the control of Dpb11 interactions 
with Slx4 or Rad9 is expected to play a key role in the control 
of DNA end resection. Therefore, the decision to specifically 
stabilize the Dpb11–Slx4 interaction should be the distinguish-
ing molecular event that transitions Dpb11’s function from 
blocking resection to favoring resection. Because interactions 
of Dpb11 with Slx4 and Rad9 are both dependent on CDK 
(Pfander and Diffley, 2011; Wang et al., 2012; Ohouo et al., 
2013; Gritenaite et al., 2014), we reasoned that CDK activity 
is unlikely to be the discerning molecular event that commands 
the choice of Slx4 versus Rad9 stabilization at DNA lesions. 
Previously, we have shown that the Dpb11–Slx4 interaction is 
strongly induced by DNA damage and requires the Mec1 ki-
nase (Ohouo et al., 2010). Here, we show that Mec1 is specifi-
cally required to enhance the Dpb11–Slx4 interaction but plays 
a minor role in the control of the Dpb11–Rad9 interaction 
(Fig. 3, A and B). During MMS-induced replication stress or 
phleomycin-induced DSBs in the G2/M transition, the Dpb11–
Slx4 interaction was largely dependent on Mec1. However, we 
observed only a slight reduction of the Dpb11–Rad9 interac-
tion upon deletion of MEC1. These results are consistent with 
the model in which Mec1 signaling plays a decisive role in 
promoting DNA end resection via Slx4 phosphorylation. To 
test this, we analyzed resection in the slx4-7MUT mutant bear-
ing mutation of seven Mec1 consensus phosphorylation sites, 
which we have previously shown to specifically impair binding 
to Dpb11 but not to impair binding to other Slx4-interacting 
proteins (Ohouo et al., 2010, 2013). As shown in Fig. 3 C, re-
section in the slx4-7MUT mutant was impaired, close to the 
level observed in cells lacking SLX4. We therefore propose a 
model in which Mec1 signaling, through the formation of a 
Dpb11–Slx4–Rtt107 complex, counteracts a resection block 
imposed by the Dpb11–Rad9 complex (Fig. 3 D).
indicated genotype were plated on YP + glucose and YP + galactose and incubated at 28°C for 3 d. The viability values were obtained by dividing the 
number of colonies grown on YP + galactose by the number of colonies growing on YP + glucose. Plotted values are the means of at least two independent 
experiments ± SD. (H) A working model for the role of the Dpb11–Slx4–Rtt107 complex in antagonizing Rad9 recruitment at lesion sites. Me, methylation. 
(I) Schematic illustration of the MBD chimera. (J) ChIP-qPCR analysis of BRCT3/4-Rad9 or BRCT3/4(K544A)-Rad9 recruitment to one irreparable HO cut 
in nocodazole-arrested JKM139-derivative strains expressing the indicated chimeric proteins. (K) DSB resection analysis by qPCR to determine the effect of 
MBD expression on resection efficiency in nocodazole-arrested JKM139-derivative strains expressing Rad9, BRCT3/4-Rad9, or BRCT3/4(K544A)-Rad9. 
(C, D, J, and K) Graphs are plotted using means ± SEM from two (K), three (D and J), or four (C) independent experiments. P-values were determined 
based on a one-tailed Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001. B3/4, BRCT3/4. (L) A working model for the role of the Slx4–Rtt107 
complex in counteracting the Dpb11-mediated recruitment of Rad9 to promote DNA end resection. For the experiments in this figure, BRCT3/4-RAD9 and 
MBD chimeras were integrated into the RAD9 and SLX4 loci, respectively. P, phosphorylation.
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Figure 2. Dpb11-mediated hyperstabilization of Rad9 impairs proper HR repair of replication-induced lesions. (A and B) Rfa1-mRuby2 foci were quan-
tified in MMS-treated cells expressing either the BRCT3/4-Rad9 chimera or the mutated BRCT3/4(K544A)-Rad9 chimera or cooverexpressing the MBD 
and BRCT3/4-Rad9 chimeras. Representative images are shown in A. Percentages of cells with one Rfa1 focus or with multiple Rfa1 foci were quantified 
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Proteomic analysis in human cells reveals 
TOP BP1 interactions with antagonistic 
repair factors
Based on our findings in yeast, we speculated that TOP BP1 also 
plays a role in coordinating the recruitment of antagonistic factors 
for the proper control of DNA repair in mammals. Previous stud-
ies revealed that TOP BP1 indeed interacts with 53BP1 as well 
as with a range of pro-HR factors, including BRCA1-associated 
proteins (Yamane et al., 2002; Greenberg et al., 2006; Morishima 
et al., 2007; Yoo et al., 2009; Cescutti et al., 2010). We reasoned 
that TOP BP1 interactions specifically induced by replication 
stress should reveal pro-HR functions for TOP BP1. We therefore 
performed an unbiased mass spectrometry analysis to define the 
network of TOP BP1 interactions in cells either treated with hy-
droxyurea (HU), to induce replication stress, or with nocodazole, 
to reveal interactions that are independent of replication stress 
(Fig. 4 A and Tables S3 and S4). Next, we measured the changes 
of the identified interactions by directly comparing cells treated 
with HU or nocodazole to specifically reveal interactions induced 
by replication stress (Fig.  4  B and Table S5). Although most 
interactions did not display major changes in our comparison 
(Fig. 4 B), the interaction of human TOP BP1 with a pro-HR fac-
tor, BRCA1, is strongly induced by replication stress (Fig. 4 B), 
similar to what we previously observed for yeast Dpb11 (Ohouo 
et al., 2010). Of interest, the interaction of TOP BP1 with 53BP1 
is reduced under replication stress (Fig. 4, B and C), suggesting 
that the interactions of TOP BP1 with BRCA1 and 53BP1 are mu-
tually exclusive. Similar results were observed when comparing 
untreated asynchronous cells with HU-treated cells (Fig. S1 C), 
further suggesting that the TOP BP1–53BP1 interaction is largely 
constitutive and is counteracted upon replication stress. This no-
tion is further supported by the findings that both of these inter-
actions are disrupted by mutations that impair the BRCT1/2 or 
BRCT4/5 domains of TOP BP1 (Fig. 4 D) and that BRCA1 could 
not be detected in a 53BP1 immunoprecipitation and vice versa 
(Fig. S1, A and B). Because 53BP1 and BRCA1 localize to sites 
of DNA lesions in a mutually exclusive manner (Chapman et al., 
2012a) and have been proposed to compete for DNA lesions to 
dictate repair pathway choice (Cao et al., 2009; Bouwman et al., 
2010; Bunting et al., 2010; Chapman et al., 2012a), our findings 
suggest that TOP BP1 could be the mediator of such competition, 
similar to the role of Dpb11 in coordinating the competition be-
tween Rad9 and Slx4 in yeast. Also similar to the yeast model, 
the ATR kinase plays an important role in promoting the inter-
action of TOP BP1 with a pro-HR factor (in this case, BRCA1) 
but is not required for enhancing the TOP BP1–53BP1 interaction 
(Fig.  4 E). Overall, these findings are consistent with a model 
in which yeast Dpb11 and mammalian TOP BP1 have roles in 
coordinating the action of antagonistic repair factors (Fig. 4 F).
Hyperstabilization of the TOP BP1–53BP1 
interaction promotes 53BP1 recruitment 
to nuclear foci in the S phase
Based on our findings in yeast, we hypothesized that human 
TOP BP1 controls the recruitment of 53BP1 to DNA lesions 
under certain conditions and is important to mediate 53BP1- 
dependent DNA repair. To test this hypothesis, we engineered 
a system to stabilize the TOP BP1–53BP1 interaction. We were 
unable to generate a chimeric mammalian protein similar to the 
BRCT3/4-Rad9 fusion we generated in yeast because fusion 
proteins of 53BP1 with BRCT domains of TOP BP1 did not ex-
press in human cell lines. To circumvent this issue, we fused 
53BP1 to a 120–amino acid region from the N-terminal domain 
of replication factor C subunit 1 (RFC1), which we found to 
constitutively interact with TOP BP1 (Fig. 4 B). Thus, by fusing 
the N terminus of RFC1 (hereafter referred to as the consti-
tutive TOP BP1-interacting region [CTR]) to 53BP1 (Fig. 5 A), 
we reasoned that the interaction of this chimera with TOP BP1 
would be stabilized and enhanced during replication stress. In-
deed, the CTR-53BP1 chimeric protein displays enhanced inter-
action with TOP BP1 after HU treatment (Fig. 5 B). Strikingly, 
the CTR-53BP1 chimera forms significantly more nuclear foci 
compared with 53BP1 alone in cells progressing through the S 
phase after release from an HU-induced arrest (Fig. 5, C and D; 
and Fig. S2 A), suggesting the enhanced recruitment of CTR-
53BP1 to replication-induced lesions.
Once recruited to the lesion site, 53BP1 promotes the re-
cruitment of PTIP and RIF1, two proteins believed to function 
as effectors of NHEJ and/or as blockers of resection (Callen 
et al., 2013; Chapman et al., 2013; Di Virgilio et al., 2013; 
Escribano-Díaz et al., 2013; Feng et al., 2013; Zimmermann 
et al., 2013). To investigate whether the increased recruit-
ment of CTR-53BP1 functionally impacts 53BP1-mediated 
DNA repair, we first monitored PTIP and RIF1 status. Inter-
estingly, CTR-53BP1 pulled down more PTIP compared with 
53BP1 alone, despite the relatively lower expression level of 
CTR-53BP1 (Fig. 5 B). In addition, although we were unable 
to monitor PTIP foci using available antibodies, we found that 
CTR-53BP1 induces a significant increase in the number of 
RIF1 foci in S-phase cells released from an HU arrest (Fig. 5, C 
and D; and Fig. S2 A). Because RIF1 and PTIP recruitment to 
DNA lesions is believed to require DNA damage–induced phos-
phorylation of 53BP1 (Munoz et al., 2007; Callen et al., 2013; 
Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Díaz et 
al., 2013; Zimmermann et al., 2013; Kumar and Cheok, 2014), 
our results strongly suggest that the enhanced interaction with 
TOP BP1 increases the engagement of CTR-53BP1 at sites of 
lesions, culminating in its phosphorylation and the subsequent 
increased recruitment of RIF1 and, likely, PTIP.
and plotted in B. More than 300 cells were scored per replicate. (C and D) Rad52-mRuby2 foci were quantified in cells expressing either BRCT3/4-Rad9 
or the mutated BRCT3/4(K544A)-Rad9 chimera or cooverexpressing the MBD and BRCT3/4-Rad9 chimeras. Cells were analyzed after treatment with 
0.033% MMS for 2 h or after recovery of cells for 2 h in fresh media after MMS treatment. Cells were evaluated based on the presence or the absence of 
Rad52-mRuby2 foci. More than 300 cells were scored per replicate. Representative images are shown in C. The percentage of cells with Rad52 foci were 
quantified and plotted in D. Bars, 5 μm. DIC, differential interference contrast. (E) MMS sensitivity of wild-type cells expressing MBD and/or BRCT3/4-Rad9 
from plasmids. Fourfold serial dilutions were spotted on SC-URA-TRP plates and grown for 2–3 d at 30°C. (F) MMS sensitivity of cells expressing either 
BRCT3/4-Rad9 or BRCT3/4(K544A)-Rad9 from the endogenous RAD9 locus. Fourfold serial dilutions were spotted on YPD plates and grown for 2–3 d at 
30°C. WT, wild type. (G) Immunoblots showing the phosphorylation status of Rad53 and BRCT3/4-Rad9 in cells expressing Rad9 or BRCT3/4-Rad9 or 
coexpressing BRCT3/4-Rad9 with MBD. The Rad9 fusions were integrated at the RAD9 locus and MBD was expressed from a plasmid (pMBS910). For 
A–D, F, and G, the BRCT3/4-Rad9 chimera was integrated into the RAD9 locus. B3/4, BRCT3/4. Graphs are plotted using means ± SEM from at least 
three independent experiments. P-values were determined based on a two-tailed Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 3. Phosphorylation of Slx4 by Mec1 promotes DNA end resection. (A) Coimmunoprecipitations of Dpb11 with Slx4 or Rad9 in wild-type (WT) 
or mec1Δ cells treated with 0.01% MMS for 3 h. (B) Coimmunoprecipitations of Dpb11 with Slx4 or Rad9 in wild-type or mec1Δ cells arrested with 
7 µg/ml nocodazole for 3 h followed by phleomycin treatment (40 µg/ml) for 15 min in the continuous presence of nocodazole. IP, immunoprecip-
itation; WCE, whole cell extract. (C) DSB resection analysis by qPCR of the indicated nocodazole-arrested JKM139-derivative strains. The graph is 
plotted using means ± SEM from two independent experiments. (D) A model for the role of Dpb11 in resection control via coordination of Slx4 and 
Rad9. P, phosphorylation.
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Figure 4. Proteomic analysis of TOP BP1 interactions modulated by replication stress. (A) Quantitative mass spectrometry analysis of TOP BP1 interactions in cells ar-
rested with HU or nocodazole. HEK293T cells were grown in light and heavy SIL AC media and were treated with 1 mM HU for 24 h to identify proteins that interact 
with TOP BP1 in response to replication stress. Two independent experiments were performed, one pulling down endogenous TOP BP1 with an anti-TOP BP1 antibody 
and the other pulling down overexpressed HA-TOP BP1 with anti-HA resin. Proteins with a TOP BP1 immunoprecipitation (IP)/mock immunoprecipitation ratio of >4 
in both experiments were considered to be specific TOP BP1 interactors. Each dot in dark color represents an identified TOP BP1 interaction. Similar procedures were 
performed in cells treated with 100 ng/ml nocodazole for 14 h to define TOP BP1 interactions in G2/M. (B) Quantitative mass spectrometry analysis of changes 
in TOP BP1 interactions in HEK293T cells treated with 1 mM HU for 24 h (grown in light SIL AC media) or treated with 100 ng/ml nocodazole for 14 h (grown in 
heavy SIL AC media). (C) Coimmunoprecipitation of TOP BP1 with BRCA1 or 53BP1 in HEK293T cells treated with 1 mM HU or 100 ng/ml nocodazole (noc) as 
described in Fig. 3 A. (D) Coimmunoprecipitation experiment determining the contribution of each pair of BRCT domains in TOP BP1 for stabilizing interactions with 
BRCA1 and 53BP1. HEK293T cells were transfected with plasmids containing TOP BP1 (wild type and the following mutants: BRCT1: K154A and K155A; BRCT5: 
K704A and W711R; and BRCT7: R1314Q) or empty vector (see Table S2) and treated with 1 mM HU for 24 h. (E) Coimmunoprecipitation of TOP BP1 with BRCA1 
or 53BP1 in the presence of ATR, ATM, or DNA-PK inhibitors. HEK293T cells transfected with HA-TOP BP1 were pretreated with ATR, ATM, or DNA-PK inhibitors for 
45 min, followed by 30-min HU treatment in the presence of inhibitors. i, inhibitor; WCE, whole cell extract. (F) Depiction of an analogous mode of TOP BP1Dpb11 
interactions with pro-HR (BRCA1 in humans and Slx4 in yeast) and anti-resection (53BP1Rad9) factors. P, phosphorylation.
A conserved role for ToP BP1Dpb11 in DNA repair • liu et al. 631
Hyperstabilization of the TOP BP1–53BP1 
interaction impairs HR-mediated repair and 
induces chromosomal aberrations
The foci formed by CTR-53BP1 colocalized with γ-H2AX and 
RIF1 but not with RPA or RAD51, two markers for HR (Fig. 
S2 B), suggesting that the chimera is engaging in RIF1-medi-
ated DNA repair in a mutually exclusive manner with the HR 
machinery. We therefore hypothesized that expression of CTR-
53BP1 would induce genomic instability by promoting muta-
genic NHEJ repair and/or deregulating HR-mediated repair. 
Indeed, we observed a significant increase in the number of 
chromosomal aberrations induced by the expression of CTR-
53BP1, but not by the expression of ectopic 53BP1, in response 
to fork collapse induced by a combination of poly(ADP-ribose) 
polymerase (PARP) inhibitor (AZD2461) and ATR inhibitor 
(VE-821; Fig.  5  E). We also generated HEK293 cells with a 
stably integrated CTR-53BP1 whose expression is induced by 
doxycycline (DOX; Fig. 5 F and Fig. S3, A and B). In these 
cells, DOX treatment led to growth sensitivity (Fig. S3 C) and 
a striking accumulation of chromosomal aberrations, especially 
radial chromosomes, upon PARP inhibition (Fig. 5, G and H). 
We could observe some radials in these cells even in the absence 
of DOX (Fig. 5 H), which we attributed to a minor leakage ex-
pression of CTR-53BP1 in the absence of DOX (Fig. S3 A). 
Of importance, we note that overexpression of 53BP1 had only 
a minor impact in the cells we used. Despite ectopic 53BP1 
being expressed at least five times more than CTR-53BP1 
(Figs. 5 B and S4 B), overexpression of 53BP1 did not result 
in a significant increase in chromosomal aberrations (Fig. 5 E). 
Collectively, these findings support a model in which TOP BP1 
mediates the recruitment of 53BP1 to DNA lesions to promote 
53BP1-dependent genomic instability.
Consistent with the model that the TOP BP1–53BP1 in-
teraction counteracts HR-mediated DNA repair, we observed 
that the expression of CTR-53BP1 reduced HR repair in the 
DR-GFP system (Fig. 5 I), a commonly used assay to test HR 
in human cells (Gunn and Stark, 2012). Again, the overexpres-
sion of 53BP1 had only a minor effect in inhibiting HR (Fig. 
S4, A and B), further consistent with the model that interac-
tion of 53BP1 with TOP BP1 is important to stabilize 53BP1 at 
DNA lesions and to counteract HR-mediated repair. Expression 
of CTR-53BP1 bearing mutations in the tudor or ubiquitina-
tion-dependent recruitment (UDR) domains, which are import-
ant for the ability of 53BP1 to localize to sites of DNA lesions, 
also failed to reduce HR repair in the DR-GFP system (Fig. S4, 
A and B), supporting the claim that the ability of CTR-53BP1 
to counteract HR requires recruitment to chromatin as well as 
TOP BP1 binding. As we observed in yeast, our results suggest 
that this effect is associated with a 53BP1-mediated block in 
DNA end resection. Although assays to measure DNA end re-
section in mammalian cells are not as well established as in 
yeast, we were able to observe a significant reduction in SSA 
repair (Fig.  5  J) through an assay that relies on extensive re-
section (Gunn and Stark, 2012) and a mild, but consistent, re-
duction in DNA end resection next to a DSB that was induced 
through the ER–AsiSI system (Figs. 5 K and S4 C; Iacovoni 
et al., 2010; Zhou et al., 2014). Finally, we noticed that the 
ability of CTR-53BP1 to induce chromosomal aberrations and 
impair HR-mediated repair was stronger upon siRNA-mediated 
knockdown of BRCA1 (Fig. 5, L and M; and Fig. S5, A and 
B). Congruent with the idea that the anti-HR function of the 
TOP BP1–53BP1 interaction is being counteracted by BRCA1, 
a partial reduction in BRCA1 abundance (Fig. S5 B) strongly 
induced chromosomal aberrations upon CTR-53BP1 expres-
sion. Overall, although further investigation will be necessary 
to understand how TOP BP1 controls recombinational DNA re-
pair and repair pathway choice, the results presented here are 
consistent with a model in which TOP BP1 mediates the compe-
tition between 53BP1 and BRCA1 for DNA lesions. As shown 
in Fig. 5 N, we propose a working model where the ability of 
TOP BP1 to bind to 53BP1 is important to stabilize 53BP1 at 
DNA lesions. In cells lacking functional BRCA1, TOP BP1 
would promote 53BP1-mediated genomic instability, possibly 
by blocking resection, impairing error-free HR-mediated repair, 
and promoting mutagenic NHEJ repair. In normal cells, ATR 
would play a role in preventing genomic instability by promot-
ing the BRCA1–TOP BP1 interaction and counteracting the en-
gagement of 53BP1 at DNA lesions.
Discussion
Maintenance of genome integrity during DNA replication heav-
ily relies on HR-mediated DNA repair. In BRCA1 mutated cells 
lacking a functional HR machinery, the scaffolding protein 
53BP1 plays a key role in promoting replication stress–induced 
chromosomal aberrations. In the last 10 years, the discovery 
that BRCA1 and 53BP1 play antagonistic roles in the control 
of DNA end resection provided a mechanistic explanation for 
how the lack of BRCA1 results in 53BP1-mediated genomic in-
stability. However, it remains incompletely understood how the 
engagement of BRCA1 and 53BP1 at DNA lesions is regulated 
and which molecular mechanisms govern a likely competition 
between these factors. In this study, we build on mechanistic 
work in yeast to propose a central and evolutionarily conserved 
role for the TOP BP1Dpb11 scaffold in controlling the engagement 
of pro- and anti-resection factors for DNA repair control. We 
provide evidence to support that interactions of Dpb11 with the 
Rad9 and Slx4–Rtt107 scaffolds define a key phosphoregulated 
molecular circuitry for resection control. We also provide ini-
tial evidence to support a model in which mammalian TOP BP1 
mediates a similar system for DNA repair control via the coor-
dinated engagement of 53BP1 and BRCA1.
Central to this circuitry for resection control is the abil-
ity of TOP BP1Dpb11 to function both as a scaffold as well as 
an activator of ATRMec1, therefore integrating the action of this 
kinase into resection control. In our proposed model depicted 
in Fig. 3 D for yeast, Dpb11 functions as a scaffolding module 
to stabilize pro- or anti-resection factors at DNA lesions, and 
activation of the Mec1 kinase plays a decisive role in shifting 
Dpb11’s role from an inhibitor of resection (via the Dpb11–Rad9 
complex) to a positive regulator of resection (via the Dpb11–
Slx4–Rtt107 complex). Interestingly, when bound to Rad9, 
Dpb11 is also coordinating Mec1 signaling, but in this case, it 
is contributing to transduce Mec1 signaling toward Rad53 acti-
vation (Puddu et al., 2008; Pfander and Diffley, 2011). Notably, 
Rad53 signaling contributes to inhibit DNA end resection by 
inhibiting the action of the Exo1 nuclease (Morin et al., 2008; 
Segurado and Diffley, 2008) and potentially promoting Rad9 
retention at the DNA lesion (Gobbini et al., 2015). Therefore, 
the Mec1-dependent shift in Dpb11 interaction from Rad9 to 
Slx4 is a key event in this circuitry, resulting in a drastically 
different output in resection control. It is tempting to specu-
late that early in the response to DNA lesions, the Dpb11–Rad9 
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Figure 5. Hyperstabilization of the TOP BP1–53BP1 interaction promotes 53BP1 recruitment and impairs HR-mediated repair. (A) Schematic illustration of 
the CTR-53BP1 chimera in which a 120–amino acid fragment in the N-terminal domain of RFC1 was fused to full-length 53BP1. (B) Coimmunopreciptitation 
experiment pulling down CTR-53BP1 and probing for TOP BP1 and PTIP in HEK293T cells treated with 1 mM HU for 24 h. Ectopic 53BP1 and CTR-53BP1 
containing an N-terminal FLAG-tag were transiently overexpressed. WCE, whole cell extract. (C) Immunofluorescence of U2OS cells transfected with FLAG-
53BP1 or FLAG-CTR-53BP1 and treated with 1 mM HU for 24 h followed by a 3-h release in fresh media. In our experience, this short release period 
enhanced the visualization of replication stress–induced nuclear foci for the indicated proteins. White dotted lines indicate nuclear boundaries. Displayed 
images were extracted from the panels in Fig. S2 A and show bars and DAPI staining. Bar, 10 µm. (D) Quantitation of results from the experiment shown 
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complex activates the checkpoint to promote, among other out-
puts, a protection for replication forks and DSB ends from detri-
mental and unregulated resection. With the subsequent buildup 
in Mec1 signaling at these sites, coordinated HR-mediated re-
pair is evoked by the phosphorylation of Slx4, which promotes 
the Dpb11–Slx4 interaction, destabilizes Rad9 engagement at 
DNA lesions, and therefore favors resection. Consistent with 
this model, our results using fusion proteins recapitulate the im-
portance of Dpb11 for the stabilization of Rad9 at DNA lesions 
and show that an MBD module competing for binding to the 
9-1-1 complex and γ-H2A can completely counteract the en-
gagement of Rad9 and strongly promote resection.
In human cells, we propose that, similar to the Dpb11- 
mediated circuitry, TOP BP1 also mediates a phosphoregu-
lated circuitry for HR control. Our results are consistent with a 
model in which the BRCA1–TOP BP1 interaction plays a role 
analogous to the Dpb11–Slx4 interaction in yeast to prevent 
TOP BP1-mediated stabilization of 53BP1 at DNA lesions. In-
terestingly, the mammalian circuitry seems to follow a similar 
regulatory logic we observed in the yeast system. Although 
TOP BP1 interacts with both BRCA1 and 53BP1, the ATR ki-
nase specifically promotes the TOP BP1–BRCA1 interaction 
but not the TOP BP1–53BP1 interaction. We speculate that the 
ATR-mediated TOP BP1–BRCA1 interaction functions simi-
larly to the Dpb11–Slx4 interaction, counteracting the TOP BP1– 
53BP1 interaction and destabilizing the engagement of 53BP1 
at DNA lesions. We note that human SLX4 was also identi-
fied as a TOP BP1 interactor, consistent with a previous study 
(Gritenaite et al., 2014). However, the interaction of TOP BP1 
with SLX4 is not enhanced by replication stress, suggesting a 
fundamentally distinct mode of interaction compared with the 
Dpb11–Slx4 interaction in yeast.
Much remains unclear about the mechanism and regula-
tion of TOP BP1 interactions with BRCA1 and 53BP1. Dissect-
ing the mechanism of these interactions will be essential to better 
understand how TOP BP1 and ATR control resection and how 
TOP BP1 helps promote 53BP1-mediated repair. Regulation of 
the TOP BP1–BRCA1 seems more complex than regulation of 
the Dpb11–Slx4 interaction in yeast, as it has been previously 
shown that ATM and DNA-PK can also promote the TOP BP1–
BRCA1 interaction (Greenberg et al., 2006). Because those 
experiments were performed in response to ionizing radiation, 
further work is necessary to precisely define the role of each 
kinase under distinct forms of DNA damage. Nonetheless, our 
results support that ATR plays a more prominent role during 
replication stress in mediating the TOP BP1–BRCA1 interac-
tion as compared with ATM and DNA-PK. This is congruent 
with the idea that ATR is a key inducer of HR-mediated repair 
during replication stress. Generation of separation-of-function 
BRCA1 mutants bearing mutations in phosphorylation sites that 
mediate interaction with TOP BP1 will be required to further de-
termine the precise extent to which ATR-mediated HR depends 
on the TOP BP1–BRCA1 interaction. We envision that ATR- 
dependent formation of the TOP BP1–BRCA1 interaction is 
likely one of the key events required for ATR-mediated resec-
tion. As such, understanding the TOP BP1-mediated circuitry for 
the phosphoregulation of resection could have implications for 
understanding how to best use ATR inhibitors in cancer therapy.
It has been recently reported that depletion of TOP BP1 ab-
rogates RAD51 loading to chromatin and formation of RAD51 
foci but does not impair DNA end resection or RPA loading 
(Moudry et al., 2016). Based on our model, we predict that in 
the experimental setup of Moudry et al. (2016), the absence of 
TOP BP1 would also impair 53BP1-mediated resection block, 
thereby allowing productive DNA end processing to occur. In 
fact, the scenario would be similar to what is observed in cells 
lacking both BRCA1 and 53BP1, where resection is restored 
as compared with cells lacking only BRCA1 (Bunting et al., 
2010). Therefore, the findings by Moudry et al. (2016) are fully 
consistent with our model that TOP BP1 is important to promote 
53BP1 functions in DNA repair. Consistent with this model, 
stabilization of the TOP BP1–53BP1 interaction reduced the 
efficiency of HR-mediated repair and resection. We acknowl-
edge that our method for monitoring resection is not yet set to 
measure resection of distances farther from the break and that 
the effect of blocking long-range resection at distances >2 kb 
from the break may be stronger, as we observed for yeast. The 
mild effect in resection may also be related to the expression 
level of the CTR-53BP1 fusion, which was not dramatically 
higher than the expression level of endogenous 53BP1 (Fig. 
S3 B). In the future, it will be interesting to measure resection 
in mutants where the TOP BP1–53BP1 interaction is disrupted 
and determine whether these mutants may restore HR-mediated 
repair in BRCA1-deficient cells. Along these lines, it will be 
in C scoring FLAG and RIF1 foci in transfection-positive cells. Graphs represent results from at least three independent experiments, and >150 transfected 
cells were scored per replicate. (E) Analysis of chromosomal abnormalities in metaphases of HEK293T cells treated with 1 µM ATR inhibitor (VE-821) and 
3 µM PARP inhibitor (AZD2461). Metaphase spreads were prepared as described in the Metaphase spread preparation section of Materials and methods. 
n > 45 metaphases were analyzed in each replicate. (F) Immunoblot showing the DOX-induced expression of CTR-53BP1. CTR-53BP1 is stably integrated 
in HEK293 cells using a Flp-In T-REx system. (G and H) Analysis of metaphase chromosomal abnormalities in HEK293 cells expressing CTR-53BP1 in 
response to PARP inhibitor. Cells were treated with DOX for 48 h, and 3 µM AZD2461 was added for another 24 h. Cells were then analyzed for chro-
mosomal aberrations. The total number of chromosomal aberrations (breaks, fusions, acentrics, and radials; G) and a subset of radial chromosomes (H) 
were scored. n > 30 metaphases were analyzed in each replicate, and each condition was repeated at least three times. (I) HR efficiency was measured 
in CTR-53BP1–expressing cells using the DR-GFP reporter system. HEK293 cells with CTR-53BP1 stably integrated were treated with DOX and transfected 
with both the pDR-GFP and pCBASceI plasmids. The GFP-positive (GFP+) cell population was analyzed by flow cytometry 48 h after transfection, and the 
percentages of GFP-positive cells were calculated in each condition. The data are normalized to the control cell line stably integrated with an empty vector. 
(J) Efficiency of SSA-mediated repair was measured in cells transiently expressing CTR-53BP1 or empty vector. U2OS SA-GFP cells were cotransfected 
with plasmids expressing CTR-53BP1 and I-SceI. GFP-positive cells were then analyzed 72 h after transfection as described in I. (K) Measurement of DSB 
resection in cells expressing CTR-53BP1 by qPCR. HEK293 cells with both CTR-53BP1 and AsiSI-ER stably integrated were treated with DOX for 48 h to 
induce CTR-53BP1 expression, followed by 4OHT treatment for another 6 h to induce DSB. (L and M) Analysis of metaphase chromosomal abnormalities 
in HEK293 cells with DOX-inducible CTR-53BP1 upon depletion of BRCA1. HEK293 cells with CTR-53BP1 stably integrated were transfected with BRCA1 
siRNA or control siRNA. At 48 h after transfection, cells were treated with 3 µM AZD2461 for 24 h and then harvested. The total numbers of chromosomal 
aberrations (L) and radial chromosomes (M) were scored. BRCA1 knockdown efficiency is shown in Fig. S5 B. (N) Model for the role of TOP BP1 in mediat-
ing a phosphorylation-regulated circuitry for the control of recombinational DNA repair. See Discussion for details. P, phosphorylation. All graphs displayed 
in this figure are plotted using means ± SEM from at least three independent experiments. P-values were determined based on a two-tailed Student’s t test. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001. 
JCB • Volume 216 • NumBer 3 • 2017634
important to define how 53BP1 (and the TOP BP1–53BP1 in-
teraction) promotes chromosomal abnormalities upon BRCA1 
deficiency. Although these abnormalities have been proposed to 
be driven by 53BP1-mediated NHEJ, it is conceivable that ge-
nomic instability may arise through deregulated and error-prone 
HR-mediated repair, as the action of 53BP1 in negatively regu-
lating resection may not completely block resection but instead 
result in aberrantly regulated resection. Overall, our findings 
presented here provide important insights into the mode of ac-
tion of TOP BP1Dpb11 in the control of DNA repair and should 
have implications for understanding how genomic instabilities 
and cancer arise in individuals with defective HR machineries.
Materials and methods
Yeast strains, plasmids, media, and growth conditions
Strains generated in this study were derived from S288C or JKM139. 
HA and FLAG tags were inserted by HR at specific genomic loci (all 
proteins were tagged at the C terminus, and the expression was veri-
fied by Western blotting). Tagged strains were assayed for sensitivity 
to MMS to ensure that they displayed similar sensitivity as wild-type 
strains. Standard cloning methods were used to generate the plasmids 
for this study. The BRCT3/4-RAD9 chimera was generated using a stitch 
PCR protocol. In brief, we fused the RAD9 promoter (450 bp upstream 
of the start codon) to the BRCT3/4 of DPB11 (corresponding to amino 
acids 292–600 of Dpb11), and the resulting PCR product was stitched 
to the RAD9-3×FLAG sequence (see Fig. 1 B for the schematic illus-
tration of the resulting chimeric protein). The final PCR product was 
subsequently cloned into pRS416 (for ectopic expression) or pFA6A 
(for integration at the endogenous RAD9 locus). All point mutations 
were generated by site-directed mutagenesis using the PrimeSTAR 
Max DNA Polymerase (Takara Bio Inc.). The plasmid for expression 
of the MBD fusion protein was constructed as previously described 
(Cussiol et al., 2015). All yeast strains and plasmids used in this study 
are described in Tables S1 and S2, respectively. Yeast cells expressing 
genes with the indicated epitope tags were cultured in YPD (yeast-pep-
tone-dextrose) medium or in synthetic complete medium lacking uracil 
and/or tryptophan when carrying an expression plasmid with URA3 or 
TRP1 (derivatives from pRS416 and pRS414, respectively). Cells were 
grown to the log phase, subjected to MMS treatment as specified in the 
figures, and collected by centrifugation. For the experiments using the 
JKM139 and YMV80 strains, cells were grown in YP (yeast-peptone) 
medium enriched with 2% glucose (YPD), 3% raffinose (YP raff), or 
3% raffinose and 2% galactose (YP raff gal). All synchronization ex-
periments were performed at 28°C.
ChIP analysis in yeast
For ChIP analysis, exponentially growing JKM139-derivative strains 
were nocodazole arrested. After HO induction, samples were collected 
at the indicated time points and cross-linked with formaldehyde for 
10 min. After centrifugation, cell pellets were washed in HBS buffer 
(50 mM Hepes, pH 7.5, 140 mM NaCl, and 1 mM EDTA, pH 8) and 
then lysed in lysis buffer (50 mM Hepes, pH 7.5, 140 mM NaCl, 1 mM 
EDTA, pH 8, and 1% Triton X-100) by bead beating. After centrif-
ugation for 30 min at 4°C, the chromatin pellet was resuspended in 
lysis buffer supplemented with Complete EDTA-free protease inhib-
itor cocktail (Roche) and 1 mM PMSF and was subjected to sonica-
tion. After two steps of centrifugation, soluble sheared chromatin was 
incubated with anti-FLAG agarose beads (Sigma-Aldrich) for 2 h at 
4°C. After immunoprecipitation, beads were washed with the follow-
ing buffers: HBS, HiSalt (50 mM Hepes, pH 7.5, 1 M NaCl, and 1 mM 
EDTA, pH 8), TL (20  mM Tris-HCl, pH 7.5, 250  mM LiCl, 1  mM 
EDTA, pH 8, and 0.5% Triton X-100), TE (20 mM Tris-HCl, pH 7.5, 
and 1 mM EDTA, pH 8). Beads were resuspended with TE + 1% SDS 
and incubated at 65°C for 2 min, and protein-bound chromatin was sep-
arated using a magnetic support. Reverse cross-linking was done over-
night at 65°C, and DNA was purified using spin columns (Promega). 
Immunoprecipated DNA and the corresponding input sample were 
analyzed by a real-time qPCR using a CFX connect (Bio-Rad Labo-
ratories). The oligonucleotides used are listed in Table S6. Data are 
presented as fold enrichment at the HO cut site (0.15 kb from the DSB) 
over that at the PRE1 locus on chromosome V and then normalized by 
the corresponding input sample. The final fold enrichment value was 
then normalized on the fold enrichment of the t0 sample.
Coimmunoprecipitation procedure in yeast
Coimmunoprecipitation experiments for yeast lysates were performed 
as described previously (Cussiol et al., 2015). In brief, cells with the 
indicated epitope tags were grown until the log phase in YPD and 
treated with MMS or arrested with nocodazole followed by phleomycin 
treatment (concentration and incubation time used for each experiment 
are described in the figure legends). After centrifugation, pellets were 
washed with TE + PMSF and kept at −80°C before cell lysis. Approx-
imately 0.1 g of cell pellet of each strain was lysed by bead beating at 
4°C in 1 ml of lysis buffer (50 mM Tris-HCl, pH 7.5, 0.2% Tergitol, 
150 mM NaCl, 5 mM EDTA, Complete EDTA-free protease inhibi-
tor cocktail, 5 mM sodium fluoride, and 10 mM β-glycerolphosphate). 
Samples were normalized by protein concentration. For Dpb11-Rad9 
coimmunoprecipitation, cell lysates were precleared by incubating with 
100 µl of human IgG Sepharose beads (IgG Sepharose 6 Fast Flow; 
17-0969-01; GE Healthcare) for 30 min at 4°C. Precleared whole-cell 
lysates were then incubated with anti-FLAG agarose resin (Sigma- 
Aldrich) for 2 h at 4°C. After three washes with lysis buffer, bound pro-
teins were eluted for 10 min at room temperature with 0.5 µg/ml FLAG 
peptide (Sigma-Aldrich) in 100 mM Tris-HCl and 0.2% Tergitol.
Mammalian expression plasmids
BRCA1, 53BP1, and CTR-53BP1 expression vectors were first generated 
in the corresponding gateway-compatible entry clones in pDONR223 
(Thermo Fisher Scientific). 53BP1 and BRCA1 were amplified from 
pcDNA5-FRT/TO-eGFP-53BP1 (Addgene plasmid 60813; a gift from 
D. Durocher; Fradet-Turcotte et al., 2013) and pCR3-BRCA1 (a gift from 
R.  Weiss, Cornell University, Ithaca, NY). The CTR-53BP1 fragment 
was created using overlapping PCR to fuse the PCR product of CTR (1–
120-aa of RFC1) with that of full-length 53BP1. CTR-53BP1, BRCA1, 
and 53BP1 were then each cloned into the pHAGE-CMV-FLAG-HA-
puro gateway destination vector, provided by A.  Smogorzewska (The 
Rockefeller University, New York, NY). To generate CTR-53BP1 vec-
tors bearing mutations in the UDR and tudor domains of 53BP1, we 
used the QuikChange Multi Site-Directed Mutagenesis kit (200515; 
Agilent Technologies) to mutate the entry clone, and the mutated entry 
clones were then transferred to the destination vector. For TOP BP1 
cloning, TOP BP1 cDNA was amplified from pGEX6P1-TOP BP1 (Ad-
dgene plasmid 20375; a gift from A. Sancar; Choi et al., 2009) and then 
cloned into pcDNA3-3HA through EcoRI and NotI restriction digestion. 
TOP BP1 mutants bearing mutations in BRCT1, BRCT5, and BRCT7 
were created using the QuikChange Multi Site-Directed Mutagenesis 
kit. FLAG-HA-CTR-53BP1 was amplified from the previously cloned 
gateway expression vector pHAGE-CMV-FLAG-HA-CTR-53BP1-puro 
and inserted into pcDNA5-FRT/TO vector using the Gibson Assem-
bly Cloning kit (E5510S; New England Biolabs, Inc.). This vector was 
then used for the generation of stable cell lines with the DOX-inducible 
expression of CTR-53BP1.
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Mammalian cell culture
Human U2OS, HEK293T, and HEK293 Flp-In T-REx cell lines were 
grown in DMEM supplemented with 10% bovine calf serum, non-
essential amino acid, and penicillin/streptomycin (Corning). The 
HEK293 Flp-In T-REx cell line for the expression of DOX-inducible 
FLAG-CTR-53BP1 and a control cell line with empty vector integrated 
were generated by stable transfection using the Flp-In T-REx system 
(R78007; Thermo Fisher Scientific) according to the manufacturer’s 
instructions and were cultured in 10% bovine calf serum/DMEM sup-
plemented with 50 µg/ml hygromycin B. To induce protein expression 
in HEK293 Flp-In T-REx cell lines, 2 µg/ml DOX was added to the 
culture media for 48  h.  Plasmid transfections were performed using 
homemade polyethylenimine (Polysciences, Inc.), jetPRI ME polyeth-
ylenimine (Polyplus), or Lipofectamine 2000 (Thermo Fisher Scien-
tific). The siRNA transfections were performed using Lipofectamine 
RNAiMax (Thermo Fisher Scientific). At 48  h after transfection, 
cells were subjected to the indicated drug treatments and then fixed 
or harvested for microscopy and immunoprecipitation experiments. 
Specifically for immunoprecipitation experiments, HEK293T cells 
were treated for either 24 h with 1 mM HU or 14 h with 100 ng/ml 
nocodazole before harvesting. For the ATR inhibition experiments 
(Fig. 4 E), cells were pretreated with the indicated inhibitors, 10 µM 
ATR inhibitor (VE-821), 10 µM ATM inhibitor (KU-55933), and 5 µM 
DNA-PK inhibitor (NU7441), for 45 min before additional treatment 
with 2.5 mM HU for 30 min.
Coimmunoprecipitation procedures in mammalian cells
For coimmunoprecipitation experiments, cell pellets were lysed for 30 
min on ice in modified radioimmunoprecipitation assay (RIPA) buf-
fer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% tergitol, 0.25% so-
dium deoxycholate, and 5 mM EDTA) supplemented with Complete 
EDTA-free protease inhibitor cocktail, 5 mM sodium fluoride, 10 mM 
β-glycerolphosphate, 1 mM PMSF, and 0.4 mM sodium orthovanadate. 
Protein lysates were cleared by 10-min centrifugation to pellet cell 
debris and then were incubated with anti-TOP BP1 resin, anti-HA, or 
FLAG agarose beads (Sigma-Aldrich) for 4 h at 4°C. Immunoprecipi-
tates were then washed three times with the modified RIPA buffer and 
then eluted using three resin volumes of the elution buffer (0.5 µg/ml 
FLAG peptide in 50 mM Tris-HCl and 0.2% tergitol for anti-FLAG 
resin; 100 mM Tris-HCl, pH 8.0, and 1% SDS for others).
Immunoblotting analysis
Whole-cell lysates and eluents were denatured with 3× SDS sample 
buffer (composed of bromophenol blue, stacking gel buffer, 50% glyc-
erol, 3% SDS, and 60  mM DTT) and resolved on SDS-PAGE gels. 
Proteins were then transferred onto polyvinylidene fluoride membranes 
and probed with the desired antibodies.
Mass spectrometry analysis
For mammalian stable isotope labeling with amino acids in cell culture 
(SIL AC) experiments, HEK293T cells were grown in SIL AC DMEM 
media lacking arginine and lysine (88425; Thermo Fisher Scientific) 
supplemented with 10% dialyzed FBS and penicillin/streptomycin. 
“Light” DMEM was supplemented with “light” (normal) arginine and 
lysine; ‘‘heavy’’ DMEM was supplemented with “heavy” lysine (13C6, 
15N2) and “heavy” arginine (13C6, 15N4). Cells were treated with 1 mM 
HU for 24 h or with 100 ng/ml nocodazole for 14 h before harvesting. 
TOP BP1 was immunoprecipitated using affinity-purified anti-TOP BP1 
antibodies or antibodies that recognize the according epitope tags. Im-
munoprecipitated proteins were then reduced, alkylated, precipitated, 
and digested by trypsin. The peptides were desalted, dried, reconsti-
tuted in 80% acetonitrile and 1% formic acid, and then fractionated by 
hydrophilic interaction chromatography. Fractions were dried, reconsti-
tuted in 0.1% trifluoroacetic acid, and analyzed by liquid chromatogra-
phy–tandem mass spectrometry using a mass spectrometer (Q Exactive 
Orbitrap; Thermo Fisher Scientific). The capillary column was 20 cm 
long with a 125-µm inner diameter, packed in-house with 3-µm, 200-A 
C18AQ particles (Prontosil). Peptides were separated over an 80-min 
linear gradient of six to 40% acetonitrile in 0.1% formic acid at a flow 
rate of 200 nl/min (Bastos de Oliveira et al., 2015). Xcalibur 2.2 soft-
ware (Thermo Fischer Scientific) was used for the data acquisition, and 
the Q Exactive was operated in the data-dependent mode. Survey scans 
were acquired in the Orbitrap mass analyzer over the range of 380 to 
2,000 m/z with a mass resolution of 70,000 (at m/z 200). The maximum 
ion injection time for the survey scan was 80 ms with a 3e6 automatic 
gain-control target ion. Tandem mass spectrometry spectra was per-
formed by selecting up to the 10 most abundant ions with a charge 
state of 2, 3, or 4 and with an isolation window of 2.0 m/z. Selected 
ions were fragmented by higher energy collisional dissociation with 
a normalized collision energy of 27, and the tandem mass spectra was 
acquired in the Orbitrap mass analyzer with a mass resolution of 17,500 
(at m/z 200). For the database search, raw tandem mass spectrome-
try spectra were searched in a SOR CER ER system (Sage-N Research, 
Inc.) using SEQ UEST software (Thermo Fisher Scientific), and all en-
tries were from the human UniProt proteome database. The following 
parameters were used in the database search: semitryptic requirement, 
a mass accuracy of 15 ppm for the precursor ions, a differential modifi-
cation of 8.0142 D for lysine and 10.00827 D for arginine, and a static 
mass modification of 57.021465 D for alkylated cysteine residues. The 
XPR ESS software, part of the Trans-Proteomic Pipeline (Seattle Pro-
teome Center), was used to quantify all the identified peptides (Bastos 
de Oliveira et al., 2015).
Chemicals and antibodies
PARP inhibitor (AZD2461), ATM inhibitor (KU-55933), DNA-PK in-
hibitor (NU7441), and ATR inhibitor (VE-821) were purchased from 
Selleckchem. Nocodazole was purchased from EMD Millipore. HU 
and MMS were purchased from Acros Organics. Antibodies used for 
the detection of yeast proteins were all mouse antibodies: anti-Rad53 
antibody (clone Mab EL7; 1:30 dilution; Abcam); anti-FLAG (M2 
F1804; 1:5,000 dilution; Sigma-Aldrich), and anti-HA (12CA5; 
1:10,000 dilution; Roche). The following antibodies were used for 
the detection of proteins in human cells: mouse antibodies include 
anti-FLAG (M2; F1804; Sigma-Aldrich), anti-HA.11 (MMS-101P; 
Covance), anti-phosphohistone H2A.X (pSer139; 05-636; JBW301; 
EMD Millipore), anti-RPA (ab2175; Abcam), and anti-BRCA1 (OP92; 
MS110; EMD Millipore); rabbit antibodies include anti-FLAG (PA1-
984B; Thermo Fisher Scientific), anti-53BP1 (NB100-304; Novus 
Biologicals), anti-phospho–KAP-1 (S824; A300-767A-T; Bethyl), 
anti-RAD51 (PC130; EMD Millipore), and anti–phospho-CHK1 
(pSer345; 2341; Cell Signaling Technology). Goat antibody was used 
for detection of RIF1 (sc-55979; Santa Cruz Biotechnology, Inc.). 
The anti-TOP BP1 and anti-BRCA1 antibodies, provided by R. Freire 
(Hospital Universitario de Canarias, Tenerife, Spain), were raised in 
rabbits injected with amino acids 900–1200 of human TOP BP1 and 
amino acids 1350–1650 of human BRCA1, respectively (Danielsen et 
al., 2009; Kakarougkas et al., 2013). The anti-PTIP antibody, provided 
by K. Ge, was generated against amino acids 274–472 of mouse PTIP 
by immunizing rabbits (Cho et al., 2009).
RNAi
Cells were transfected with the indicated siRNA using Lipofectamine 
RNAiMAX according to the manufacturer’s instructions. The siRNA 
against BRCA1 (BRCA1 HSS101089; 5′-AAA UGU CAC UCU GAG 
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AGG AUA GCCC-3′) was purchased from Thermo Fisher Scien-
tific. Medium GC stealth RNAi siRNA Negative Control (12935300; 
Thermo Fisher Scientific) was used as control.
Immunofluorescence
U2OS cells grown on glass coverslips were fixed with 3.7% formalde-
hyde/PBS for 15 min at room temperature. Cells were then permeabi-
lized with 0.2% Triton X-100 in PBS for 5 min at room temperature, 
blocked with 5% BSA for 30 min at 37°C, and then incubated with 
primary antibodies for 1 h at room temperature. This was followed by 
three washes with PBS and secondary antibody incubation with Alexa 
Fluor 488 donkey anti–rabbit (A-21206), Alexa Fluor 594 donkey anti–
mouse (A-21203), or Alexa Fluor 647 donkey anti–goat (A-21447; 
Thermo Fisher Scientific). Next, cells were washed with PBS three 
times and mounted using Vectashield Antifade mounting medium with 
DAPI (H1200; Vector Laboratories).
Microscopy analysis
Images were acquired at room temperature using a spinning-disc con-
focal microscope (CSU-X; Yokogawa Electric Corporation and Intel-
ligent Imaging Innovations) on an inverted microscope (DMI600B; 
Leica Biosystems) with a 63×, 1.4 NA objective lens for mammalian 
cells or a 100×, 1.46 NA objective lens for yeast and mammalian 
cells and a charge-coupled device camera (cool-SNAP HQ2; Photo-
metrics) for mammalian cells or an electron-multiplying charge-cou-
pled device camera (QuantEM; Photometrics) for yeast cells. 488, 
561, and 640-nm laser lines were used for the excitation of Alexa 
Fluor 488-, 594-, and 647 dyes, respectively, in immunofluorescence 
microscopy. 488- and 561-nm laser lines were used for the detec-
tion of mRuby and GFP-tagged proteins in yeast cells, respectively. 
SlideBook software (Intelligent Imaging Innovations) was used to 
obtain Z stack images. Maximum intensity projections were created 
in the Slidebook software for foci number analysis. For the analysis 
of foci formation of mammalian RIF1 or of FLAG-tagged 53BP1 or 
CTR-53BP1, >150 transfected cells for each condition were imaged 
and analyzed per replicate. Cells with >10 distinct RIF1 or FLAG 
foci were scored as foci-positive cells. The percentages of RIF1 or 
FLAG foci–positive cells were calculated based on the arithmetic 
mean and SEM derived from three biological replicates. A two-tailed 
Student’s t test with 95% confidence interval was used to determine 
whether the difference between the means of two sets of values was 
significant. For yeast Rfa1 and Rad52 foci analysis, cells were grown 
in synthetic complete lacking tryptophan media until the log phase 
(OD = 0.3), and MMS (0.033%) was added to the cells for 2 h at 
30°C. Next, cells were washed in sterile water and resuspended in 
fresh synthetic complete media. Live yeast cultures were mounted 
on an agarose slide pad (1.2% agarose in SC-TRP media) and >150 
cells were scored for each replicate. The percentages of cells with 
multiple Rad52-mRuby2 foci or containing a single Rfa1-mRuby2 
focus or multiple Rfa1-mRuby2 foci were calculated based on the 
arithmetic mean and SEM derived from three independent replicates. 
A two-tailed Student’s t test with a 95% confidence interval was used 
to determine whether the difference between the means of two sets 
of values was significant.
Metaphase spread preparation
HEK293T cells were cotransfected with plasmids for expression of 
53BP1 or CTR-53BP1, together with a plasmid for expression of 
H2B-GFP (Addgene plasmid 11680) used as a marker for transfec-
tion. In Flp-In T-REx 293 cells with CTR-53BP1 stably integrated, 
protein expression was induced using 2 µg/ml DOX for 48 h, fol-
lowed by the indicated genotoxin treatment. Cells were then treated 
with 150 ng/ml colcemid for 1  h and collected by trypsinization 
followed by centrifugation. Cell pellets were resuspended in hypo-
tonic buffer (0.034  M KCl) for 6 min at 37°C and then fixed in 
fixation buffer (3:1 of methanol and acetic acid) overnight. Fixed 
cells were then washed with fixation buffer three times, spotted onto 
a microscope slide, and mounted using Vectashield Antifade mount-
ing medium with DAPI. Metaphase spreads were imaged using the 
CSU-X spinning disc confocal microscope with 100×, 1.46 NA ob-
jective. Chromosomal aberrations were then scored. Each condition 
was repeated at least two times independently, and 30–50 meta-
phases were analyzed per replicate. The two-tailed Student’s t test 
was used for statistical analysis.
Cell survival assay
HEK293 Flp-In T-REx cells with stably integrated CTR-53BP1 and 
the control cell line were seeded in DOX-containing media for 48 h to 
induce CTR-53BP1 expression. Cells were then subjected to genotoxin 
treatment in the continuous presence of DOX for 72 h before cells were 
counted. The percentage of survival was calculated, and the graph was 
plotted based on at least three independent experiments showing means 
± SEM. The two-tailed Student’s t test was used for statistical analysis.
Measurement of resection at HO-induced DSB in yeast
HO-induced DSB resection was measured in JKM139 background 
by qPCR analysis as described previously (Ferrari et al., 2015). Cells 
were arrested in G2/M by nocodazole treatment before HO induction. 
Genomic DNA was extracted and digested or mock treated with RsaI 
restriction enzyme (New England Biolabs, Inc.), which cuts inside the 
amplicons at 0.15, 1.4, and 4.8 kb from the HO cut site, but not in the 
PRE1 control region on chromosome V. PCR values are then normal-
ized by the cut efficiency calculated by Southern blot analysis, with a 
probe around the HO cut site.
SSA repair analysis in yeast
SSA repair efficiency of an HO endonuclease–induced DSB in YMV80 
background was analyzed using Southern blotting procedures (Vaze 
et al., 2002; Ferrari et al., 2015). In brief, cells grown in YP medium 
containing 3% lactate at 28°C reaching a density of 5 × 106 cells/ml 
were arrested with 20 µg/ml nocodazole, followed by the addition of 
2% galactose to trigger a single DSB by inducing HO endonuclease 
expression. Cells remained arrested after DSB induction as confirmed 
by FACS and monitoring nuclear division. At the indicated time points, 
cells were collected to isolate genomic DNA, which was then subjected 
to Southern blotting analysis to determine the loss of 5′ ends at the HO 
cut MAT locus (Lee et al., 1998; Vaze et al., 2002; Clerici et al., 2005). 
Each experiment was repeated at least three times independently, and 
one representative result is shown.
DR-GFP assay
HEK293 Flp-In T-REx cells with CTR-53BP1 or empty vector stably 
integrated were cultured in DMEM containing 2 µg/ml DOX and trans-
fected with plasmid-carrying DR-GFP (pDR-GFP; Addgene plasmid 
26475) and pCBASceI (Addgene plasmid 26477; gifts from M. Jasin; 
Pierce et al., 1999). In the case of BRCA1 knockdown, cells were 
transfected with BRCA1 siRNA (BRCA1 HSS101089; Thermo Fisher 
Scientific), and 48 h after siRNA transfection, cells were transfected 
with the plasmids pDR-GFP and pCBASceI. The GFP-positive cell 
population was analyzed 48  h after transfection. The percentage of 
GFP-positive cells was quantified in each condition by flow cytometry 
analysis using FAC SAria Fusion (BD) and normalized by the control 
cell line where empty vector was integrated. The data are presented 
as means ± SEM (n > 3).
A conserved role for ToP BP1Dpb11 in DNA repair • liu et al. 637
SSA repair assay in mammalian cells
U2OS-SA-GFP cells (a gift from J. Stark; Gunn and Stark, 2012) were 
cotransfected with 0.5 µg I-SceI plasmid and 0.5 µg of plasmid ex-
pressing CTR-53BP1 or empty vector using Amaxa Nucleofector II in 
a 60-mm plate. Cells were grown for 3 d, harvested, and subjected to 
flow cytometry analysis using FAC SAria and FAC SDiva software (BD) 
to determine the percentage of GFP-positive cells.
Measurement of resection at one AsiSI-induced DSB in human cells
Resection assay was performed as described previously by Zhou et 
al. (2014) with some modifications. In brief, HEK293 cells stably ex-
pressing CTR-53BP1 or control cells stably transfected with an empty 
vector were transfected with the pBabe-AsiSI–ER plasmid (Iacovoni 
et al., 2010) using Lipofectamine 3000 (Thermo Fisher Scientific), and 
selection was performed using 1 µg/ml puromycin. Cells were seeded 
on a well of a 6-well plate. After 24 h, 2 µg/ml DOX was added to 
induce expression of the CTR-53BP1 protein. 48  h after induction, 
300 nM 4-hydroxytomoxifen (4OHT; Sigma-Aldrich) was added for 
6 h to create AsiSI-induced DSBs. For experiments with transient ex-
pression of CTR-53BP1, U2OS-AsiSI-ER cells were transfected with 
empty vector or the plasmid-expressing CTR-53BP1 using Amaxa 
Nucleofector II. 4OHT was added for 6 h to induce DSBs 48 h after 
transfection. After 4OHT treatment, cells were collected, and genomic 
DNA was extracted and eluted in a final volume of 100 µl using the 
NucleoSpin Tissue kit (MAC HER EY-NAG EL). Then, 15 µl genomic 
DNA was digested or mock digested with 20 U BsrGI enzyme (New 
England Biolabs, Inc.) in a final volume of 90 µl at 37°C overnight. 
The mix was incubated at 80°C for 20 min to inactivate the BsrGI en-
zyme and diluted twofold. 5 µl of diluted mix from either the digested 
or mock-digested sample (∼40 ng) was used as a template in a 25-µl 
qPCR reaction containing 12.5 µl of 2× master mix containing SYBR 
green (Genespin) and 0.2 µM of each primer using a CFX Connect Real 
Time system (Bio-Rad Laboratories). Primers listed in Table S7 were 
used to analyze resection at 335 and 1,618 bp from the AsiSI cut site 
on Chromosome 1. The percentage of resection at selected DSB sites 
was determined from qPCR reactions by using the formula, % DSB 
resected = 100/[(1 + 2ΔCt)/2]/f (Zierhut and Diffley, 2008), where ΔCt 
is obtained by subtracting the Ct values of mock-digested samples from 
the Ct values of digested samples, and f is the cut efficiency calculated 
from qPCR reaction with the primers “Across DSB” using the formula, 
f = 1 − 2−ΔCt, where ΔCt is obtained by subtracting the Ct value of the 
untreated sample from the Ct value of the 4OHT-treated sample.
Online supplemental material
Fig. S1 shows that BRCA1 and 53BP1 are not detected in pull-downs 
of 53BP1 and BRCA1, respectively, and that their interaction with TOP 
BP1 is oppositely regulated by HU. Fig. S2 demonstrates that CTR-
53BP1 promotes the recruitment of the NHEJ factor RIF1 to DNA 
damage foci. Fig. S3 presents the characterization of a HEK293 stable 
cell line generated for the DOX-inducible expression of CTR-53BP1. 
Fig. S4 shows that the expression of CTR-53BP1 leads to a stronger 
impairment in HR compared with overexpression of 53BP1. Fig. S5 
shows the data used for determining the effect of CTR-53BP1 expres-
sion and BRCA1 depletion on the accumulation of chromosomal aber-
rations. Tables S1 and S2 describe the yeast strains and plasmids used 
in this study, respectively. Tables S3 and S4 show the mass spectrome-
try analysis results of TOP BP1 interactions in cells arrested by HU and 
nocodazole, respectively. Table S5 shows the mass spectrometry anal-
ysis result comparing TOP BP1 interactions in HU versus nocodazole. 
Table S6 lists the oligonucleotide sequences used for ChIP and DSB 
resection analysis in yeast. Table S7 lists the oligonucleotide sequences 
used for the measurement of DSB resection in human cell lines. 
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